“The RE-UNITE-PN Study Design – A Prospective, Non-Interventional, Phase 4 Study of Nemolizumab for the Treatment of Prurigo Nodularis” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s767. doi:10.25251/q0ctfz86.